Friday, July 31, 2020 10:30:01 PM
Absolutely entitled to your opinion of course, and I understand your doubt. Things haven't gone smoothly over the last two months, as far as the stock is concerned. But I'll repeat that, and emphasize it. Things havent gone smoothly as far as the stock is concerned. That means nothing to me if the business plan is coming along as expected. If NDTP markets a sports drink that does what Gatorade does....only orders of magnitude better and more efficiently....the stock is going to fly. If NDTP licenses their technology, so that existing drugs are enabled to cross the blood brain barrier, the stock is going to fly. I could go on and on, but you know all that already. If this company becomes what you thought it would be when you first bought shares, you know it's going to be one heck of a fun ride up, up, up. I, for one, will gladly forgive management for making one or two "stock blunders" when NDTP is trading on Nasdaq and $3.40 can't even be seen in the rear view mirror because it's so far gone.
Just my humble opinion, as always.....
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM